SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950124-05-003900
Filing Date
2005-06-21
Accepted
2005-06-21 13:48:57
Documents
5
Period of Report
2005-06-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v10097e8vk.htm 8-K 18186
2 EXHIBIT 10.1 v10097exv10w1.txt EX-10.1 16289
3 EXHIBIT 10.2 v10097exv10w2.txt EX-10.2 92991
4 EXHIBIT 10.3 v10097exv10w3.txt EX-10.3 29553
5 EXHIBIT 10.4 v10097exv10w4.txt EX-10.4 4015
  Complete submission text file 0000950124-05-003900.txt   162580
Mailing Address
Business Address 21720-23RD DRIVE SE, SUITE 100 BOTHELL WA 98021 4256083000
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-33393 | Film No.: 05907600
SIC: 2834 Pharmaceutical Preparations